We are live on ! Find out more
MYIA

Mount Yale Investment Advisors Portfolio holdings

AUM $4.31B
1-Year Est. Return 21.13%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+21.13%
3 Year Est. Return
+69.37%
5 Year Est. Return
+92.43%
10 Year Est. Return
AUM
$881M
AUM Growth
+$128M
Cap. Flow
+$74.6M
Cap. Flow %
8.47%
Top 10 Hldgs %
26.29%
Holding
501
New
59
Increased
176
Reduced
198
Closed
49

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$7.39M
2
MRK icon
Merck
MRK
+$6.96M
3
ORCL icon
Oracle
ORCL
+$5.88M
4
T icon
AT&T
T
+$4.69M
5
EFG icon
iShares MSCI EAFE Growth ETF
EFG
+$2.75M

Sector Composition

Rank Sector Weight
1 Technology 23.19%
2 Healthcare 10.44%
3 Financials 9.49%
4 Consumer Discretionary 6.9%
5 Industrials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLLI icon
426
Ollie's Bargain Outlet
OLLI
$4.8B
$212K 0.02%
4,536
-39
-0.9% -$2.1K
KEX icon
427
Kirby Corp
KEX
$7B
$212K 0.02%
3,301
-943
-22% -$62.9K
EHC icon
428
Encompass Health
EHC
$12.5B
$211K 0.02%
+3,525
New +$192K
HALO icon
429
Halozyme
HALO
$12.2B
$210K 0.02%
+3,683
New +$189K
MTSI icon
430
MACOM Technology Solutions
MTSI
$22.7B
$209K 0.02%
3,317
-609
-16% -$38K
CAJ
431
DELISTED
Canon, Inc.
CAJ
$207K 0.02%
9,538
-10,552
-53% -$235K
ACA icon
432
Arcosa
ACA
$7.11B
$204K 0.02%
+3,745
New +$222K
TMDX icon
433
Transmedics
TMDX
$3.07B
$203K 0.02%
+3,285
New +$175K
EG icon
434
Everest Group
EG
$14.2B
$202K 0.02%
611
-358
-37% -$112K
CVX icon
435
Chevron
CVX
$382B
$202K 0.02%
+1,125
New +$196K
TTMI icon
436
TTM Technologies
TTMI
$13.7B
$193K 0.02%
12,770
+188
+1% +$2.79K
VRRM icon
437
Verra Mobility
VRRM
$720M
$185K 0.02%
13,396
+219
+2% +$3.33K
INN
438
Summit Hotel Properties
INN
$670M
$178K 0.02%
24,605
+5,390
+28% +$42.2K
AGEN
439
Agenus
AGEN
$291M
$174K 0.02%
3,684
EVRI
440
DELISTED
Everi Holdings
EVRI
$171K 0.02%
11,893
-2,753
-19% -$45.7K
LADR
441
Ladder Capital
LADR
$1.22B
$166K 0.02%
16,552
+263
+2% +$2.73K
PBR icon
442
Petrobras
PBR
$118B
$164K 0.02%
15,435
-25,130
-62% -$303K
ORAN
443
DELISTED
Orange
ORAN
$157K 0.02%
15,885
-9,804
-38% -$94.7K
GGB icon
444
Gerdau
GGB
$9.74B
$93K 0.01%
+21,140
New +$90.9K
ENIC icon
445
Enel Chile
ENIC
$6.2B
$69.7K 0.01%
30,968
+8,219
+36% +$15.1K
TLRY icon
446
CALL
Tilray
TLRY
$602M
$53.8K 0.01%
2,000
NVTA
447
DELISTED
Invitae Corporation
NVTA
$41.9K ﹤0.01%
22,511
-238,806
-91% -$583K
BPTH
448
DELISTED
Bio-Path Holdings Inc
BPTH
$38.3K ﹤0.01%
1,268
TLRY icon
449
Tilray
TLRY
$602M
$29.6K ﹤0.01%
1,100
AUVI
450
DELISTED
Applied UV, Inc. Common Stock
AUVI
$22.6K ﹤0.01%
200

Similar funds

Mount Yale Investment Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Mount Yale Investment Advisors held 501 positions worth $881M, up 17% from $753M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Mount Yale Investment Advisors deployed $74.6M of net new capital in Q4 2022, opening 59 new positions and adding to 176 existing holdings. Its largest new stake was iShares MSCI ACWI ex US ETF: 243,627 shares worth $11.1M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Merck, an estimated $6.96M trimmed.

  • Mount Yale Investment Advisors's largest Q4 2022 buy was iShares MSCI ACWI ex US ETF: 243,627 shares worth $11.1M.
  • Mount Yale Investment Advisors added most to iShares Core S&P 500 ETF in Q4 2022, an estimated $8.04M increase.
  • Mount Yale Investment Advisors's biggest Q4 2022 reduction was Merck, cutting an estimated $6.96M.
  • Mount Yale Investment Advisors fully exited Gilead Sciences in Q4 2022, selling an estimated $7.39M.
  • Mount Yale Investment Advisors's ten largest holdings make up 26% of its $881M portfolio in Q4 2022.
  • Mount Yale Investment Advisors opened 59 new positions and closed 49 in Q4 2022.
  • Mount Yale Investment Advisors's portfolio value rose 17% quarter-over-quarter to $881M.

Based on Mount Yale Investment Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.